Our commitment to quality

We ensure our content is always unique, unbiased, supported by evidence. Each piece is based on a review of research available at the time of publication and is fact-checked and medically reviewed by a topic expert.

  • Written by: Chloe Girvan & Miranda Kusi

  • Medically reviewed by: Lara Zakaria PharmD, CNS, IFMCP

Hypothyroidism is a prevalent endocrine disorder characterized by an underactive thyroid gland, leading to insufficient production of thyroid hormones. Based on data from the National Health and Nutrition Examination Survey (NHANES) conducted by the Centers for Disease Control and Prevention (CDC), the prevalence rate of hypothyroidism grew from 9.6% in 2009 to 14.4% in 2019 in the United States. (Wyne 2022)

According to the American Academy of Family Physicians (AAFP), the primary screening test for thyroid dysfunction is the measurement of serum thyroid-stimulating hormone (TSH). (American Thyroid Association 2024)(Vasileiou 2020) Although assessment guidelines often focus on TSH levels alone for diagnosis and management, a case can be made for whole person care that incorporates comprehensive lab assessment along with patient symptoms and underlying factors that may be affecting thyroid function.

Understanding hypothyroidism

Hypothyroidism can be classified into primary, secondary, and tertiary forms. Primary hypothyroidism is the most common and occurs due to thyroid gland dysfunction. Secondary hypothyroidism is characterized by insufficient TSH production by the pituitary gland, leading to reduced thyroid hormone synthesis and subsequent hypothyroid symptoms. Tertiary hypothyroidism is characterized by the insufficient production of thyrotropin-releasing hormone (TRH) by the hypothalamus, leading to a cascade of hormonal deficiencies that ultimately result in reduced thyroid function.

It’s worth mentioning that autoimmune conditions, particularly Hashimoto's thyroiditis (HT), are the leading cause of hypothyroidism. (Mikulska 2022)(Patil 2024) The prevalence of HT, which is rising globally, varies by region and socioeconomic level and ranges from 4.8–25.8% in women and 0.9–7.9% in men. (Hu 2022) These statistics highlight how disproportionately women are affected by hypothyroidism, with prevalence rates up to eight times higher than in men. (Chiovato 2019) Furthermore, hormonal fluctuations during menstruation, (Jacobson 2018) pregnancy, (Singh 2023) and menopause (Xu 2023) can significantly influence thyroid function in women.

In the United States, the rates of hypothyroidism–a condition more common in women–grew from 9.6% in 2009 to 14.4% in 2019. 

Assessment and diagnosis of hypothyroidism

Measurement of serum TSH levels is the primary screening test for thyroid dysfunction. According to the AAFP guidelines, TSH elevation is sufficient for diagnosing hypothyroidism. The reference range for normal TSH varies from lab to lab, but the American Thyroid Association suggests that the standard reference range for low-end normal TSH is 0.4 mIU/L, with the upper-end normal range ranging from 4–4.5 mIU/L. (American Thyroid Association 2020) A thyroxine (T4) level is often drawn in reflex to a high TSH to distinguish clinical (low FT4) from subclinical (normal FT4) hypothyroidism.

The limitations of TSH-only testing

Relying solely on TSH testing can miss subclinical hypothyroidism and other thyroid dysfunctions. TSH levels may appear normal even when patients exhibit symptoms of hypothyroidism, (Ling 2018) underscoring the need for a more comprehensive assessment. Furthermore, TSH testing alone doesn't account for factors like nutrient deficiencies, (Krishnamurthy 2021) adrenal health, (Rizzo 2020) or environmental toxins, (Egalini 2022) which can all impact thyroid function.

Benefits of a whole person care approach to thyroid health

Functional and integrative medicine prioritizes a whole person care approach, addressing the root causes of thyroid dysfunction rather than just the symptoms. This method can lead to effective and sustainable health outcomes by considering dietary, lifestyle, and environmental factors alongside traditional medical assessments.

This might include assessing the classic symptoms associated with hypothyroidism, such as fatigue, weight gain, cold intolerance, dry skin, and hair loss, as well as less specific but common symptoms like bradycardia, hoarseness, and menstrual irregularities that often also present in these patients. The latter may require additional differential evaluation and testing to identify the root cause. When hypothyroidism is properly treated, often those related symptoms will also resolve or improve.

(NIDDK 2022)(Wilson 2021)

Beyond TSH: Comprehensive thyroid testing

A comprehensive thyroid assessment includes evaluating the following biomarkers in addition to TSH. Interpreting these biomarkers requires an understanding of their interplay and how they correlate with patient symptoms. (Soh 2022) It’s important to emphasize that correlating lab results with clinical presentation, including symptoms such as fatigue, weight gain, and cold intolerance, can provide critical context for lab findings, leading to a more accurate diagnosis and effective treatment plan.

Total thyroxine and triiodothyronine

Total thyroxine (T4) and total triiodothyronine (T3) levels measure the total levels of T4 and T3 hormones, including both bound and unbound forms. These can be helpful in certain clinical scenarios to optimize thyroid function. (Soh 2022)

Free thyroxine and triiodothyronine

Unlike total levels, free T4 (FT4) and free T3 (FT3) tests measure only the amount of unbound T4 and T3 in the bloodstream, respectively. This offers a more accurate assessment of the free or more bioavailable form of the hormones. (Soh 2022)

Reverse T3

Reverse T3 (rT3) measures this less active form of T3 hormone. This test is especially useful in assessing thyroid hormone metabolism and evaluating thyroid dysfunction in cases of high stress and adrenal involvement. (Van Uytfanghe 2023)

T4 and T3 uptake

Measuring T3 and T4 uptake helps assess the availability of thyroid hormone binding sites and provides a clearer picture of hormone activity in the body. T4 uptake is particularly useful for calculating the free thyroxine index (FTI), which remains constant despite variations in binding proteins, aiding in accurate diagnosis of thyroid conditions. (Pantalone 2015)(Van Uytfanghe 2023)

Autoimmune testing

Autoimmune testing involves comprehensive testing for various thyroid antibodies, including:

  • Thyroid peroxidase antibodies (TPOAb): These antibodies target the thyroid peroxidase enzyme impacting the production of thyroid hormone and are commonly elevated in Hashimoto’s thyroiditis. (Soh 2022)

  • Thyroglobulin antibodies (TgAb): These antibodies target thyroglobulin, a protein involved in thyroid hormone synthesis, and are associated with Hashimoto's hypothyroidism. (Soh 2022)

  • Thyroid-stimulating immunoglobulin (TSI): TSI measures the presence of TSH receptor antibodies, making it a useful marker for diagnosing Grave’s disease. (Soh 2022)

A comprehensive assessment combining laboratory and functional testing helps clinicians gain insights into contributing factors impacting thyroid health and overall well-being.

Additional factors affecting thyroid function

The assessment of root cause influences on thyroid health should consider lifestyle and environmental factors, including nutrition, stress, and environmental considerations.

Nutrition

Nutritional deficiencies can significantly impact thyroid health. Ensuring adequate intake of these nutrients is essential for optimal thyroid function:

  • Selenium: Selenium is crucial for the production of thyroid hormones and the conversion of T4 to the more active T3 hormone. Selenium deficiency can lead to impaired thyroid hormone metabolism, increased oxidative stress, and a heightened risk of autoimmune thyroid diseases. (Gorini 2021)

  • Iron: Iron is essential for thyroid hormone synthesis and metabolism. Iron deficiency can lead to impaired thyroid hormone production by reducing the activity of the thyroid peroxidase enzyme and diminishing the conversion of T4 to T3, resulting in hypothyroidism and exacerbating its symptoms. Iron deficiency also influences the risk of thyroid autoimmunity, raising the likelihood of conditions such as Hashimoto's thyroiditis. (Garofalo 2023)

  • Vitamin B12: B12 deficiency can impair the conversion of T4 to T3, thereby reducing the overall activity of thyroid hormones. (Krishnamurthy 2021)

  • Zinc: Zinc plays a role in thyroid hormone synthesis and regulation, as well as immune activity. Zinc deficiency can impair thyroid function, reduce the conversion of T4 to T3, and increase the risk of hypothyroidism and autoimmune thyroid disease. (Krishnamurthy 2021)

  • Vitamin D: Adequate vitamin D levels are important for thyroid health, as vitamin D deficiency has been associated with autoimmune thyroid disorders and impaired thyroid function. (Zhao 2021)

The gut and microbiome

Gut health and the microbiome play a crucial role in thyroid function. A healthy gut ensures the efficient absorption of essential nutrients that are vital for thyroid hormone production. Disruptions in the gut microbiome as well as increased intestinal permeability (leaky gut) can trigger immune responses that attack the thyroid, exacerbating autoimmune thyroid conditions like Hashimoto's thyroiditis. Additionally, an imbalanced microbiome can increase systemic inflammation and immune dysregulation, negatively impacting thyroid function. (Bargiel 2021)

Adrenal health

Chronic stress and adrenal dysfunction can impair thyroid function through multiple mechanisms. This includes suppressing hormone production, impairing the conversion of thyroid hormones, triggering autoimmune responses, and disrupting gut health and nutrient absorption. Managing stress through lifestyle changes and other interventions is essential for maintaining thyroid health and overall well-being. (Kyriacou 2023)

Environmental toxins

Exposure to environmental toxins such as heavy metals (e.g., mercury and lead) and endocrine disruptors (e.g., bisphenol A (BPA) and phthalates) can significantly impair thyroid function. (Calsolaro 2021) These toxins can interfere with thyroid hormone synthesis, disrupt hormone signaling, and contribute to thyroid gland inflammation. Identifying sources of these toxins and minimizing exposure is an essential component of integrative thyroid care.

Utilizing comprehensive laboratory assessment

Laboratory testing provides essential information about thyroid function and autoimmune activity. Furthermore, combining functional testing with traditional laboratory tests helps clinicians gain insight into contributing factors that can impact thyroid health and overall well-being.

When assessing thyroid function, clinicians may wish to consider the following thyroid lab test panels, combining advanced markers with traditional tests.

1. Start with a comprehensive thyroid panel test

This includes a basic TSH and T4 (free and total T4), along with free T3, total T3, reverse T3, and thyroid antibodies (e.g. TgAb, TPOAb). These tests provide a broad-spectrum analysis of thyroid function.

2. Add on functional medicine labs

Focus on potential root causes of hypothyroidism including micronutrients and gut health, which might influence thyroid function.

  • Nutrition testing: Evaluate nutritional status using foundational nutritional laboratory testing for various vitamins and minerals and/or more advanced functional nutrition testing such as urinary organic acids.

  • GI/microbiome stool tests: Assess imbalances in the gut microbiome and digestive function that may contribute to hormonal and inflammatory dysfunction and therefore impact the physiologic function and metabolic activity of thyroid hormones. (Bargiel 2021)(De Freitas Cayres 2021)

  • Environmental/toxin panels: These panels evaluate exposure to potential thyroid disruptors like heavy metals and endocrine-disrupting chemicals. (Egalini 2022)

The bottom line

Incorporating a comprehensive assessment for hypothyroidism beyond TSH can significantly improve patient outcomes. By embracing a functional and integrative approach, clinicians can address the root causes of thyroid dysfunction and provide more personalized care.

Ready to start gathering better clinical context?

Order, manage and review diagnostic testing easier than ever before on Fullscript.

About the contributors

Miranda Kusi, CNS

Certified Nutrition Specialist

Miranda is a Certified Nutrition Specialist (CNS) with several years of experience in content creation (articles, recipes, newsletters, social media), educational webinar management and clinical nutrition counselling. She holds a MS degree in Human Nutrition as well as diplomas in culinary nutrition, life coaching and public relations and a bachelor's degree in Communication and Media Studies. Miranda is very passionate about health promotion & education and hopes to inspire others to take charge of their health and transform their lives.

Chloe Girvan

Medical Writer

Although a lawyer by trade, Chloe’s career has been focused mainly on freelance writing and communications roles. She is passionate about healthcare, politics, education, and community building. Believing that everyone has a story, and something valuable to contribute, Chloe feels privileged to have been able to build a career that allows her to listen, learn and work to make a positive difference.

Lara Zakaria , PharmD, MS, CDN, CNS, IFMCP

Fullscript Medical Advisor

Dr. Lara Zakaria is a Pharmacist, Nutritionist, and professor specializing in Functional Medicine and Personalized Nutrition. In addition to running a clinical practice focused on providing patients with sustainable solutions that address chronic disease, she also spends her time teaching and mentoring clinicians interested in implementing nutrition and food as medicine principles into practice.

References

  1. American Thyroid Association. (2020, January). Summaries for the Public from recent articles in Clinical Thyroidology. CLINICAL THYROIDOLOGY FOR THE PUBLIC A publication of the American Thyroid Association. https://www.thyroid.org/patient-thyroid-information/ct-for-patients/january-2020/vol-13-issue-1-p-5-6/

  2. American Thyroid Association. (2024). ATA Guidelines & Statements. American Thyroid Association Guidelines and Surgical Statements. https://www.thyroid.org/professionals/ata-professional-guidelines/

  3. Bargiel, P., Szczuko, M., Stachowska, L., Prowans, P., Czapla, N., Markowska, M., Petriczko, J., Kledzik, J., Jędrzejczyk-Kledzik, A., Palma, J., Zabielska, P., & Maciejewska-Markiewicz, D. (2021). Microbiome Metabolites and Thyroid Dysfunction. Journal of clinical medicine, 10(16), 3609. https://doi.org/10.3390/jcm10163609

  4. Calsolaro, V., Pasqualetti, G., Niccolai, F., Caraccio, N., & Monzani, F. (2017). Thyroid Disrupting Chemicals. International journal of molecular sciences, 18(12), 2583. https://doi.org/10.3390/ijms18122583

  5. Cayres, L. C. F., de Salis, L. V. V., Rodrigues, G. S. P., Lengert, A. V. H., Biondi, A. P. C., Sargentini, L. D. B., Brisotti, J. L., Gomes, E., & de Oliveira, G. L. V. (2021). Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis. Frontiers in immunology, 12, 579140. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973118/

  6. Chiovato, L., Magri, F., & Carlé, A. (2019). Hypothyroidism in context: Where we’ve been and where we’re going. Advances in Therapy, 36(S2), 47–58. https://doi.org/10.1007/s12325-019-01080-8

  7. Egalini, F., Marinelli, L., Rossi, M., Motta, G., Prencipe, N., Rossetto Giaccherino, R., Pagano, L., Grottoli, S., & Giordano, R. (2022). Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands. Endocrine, 78(3), 395–405. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637063/

  8. Garofalo, V., Condorelli, R. A., Cannarella, R., Aversa, A., Calogero, A. E., & La Vignera, S. (2023). Relationship between iron deficiency and THYROID FUNCTION: A systematic review and meta-analysis. Nutrients, 15(22), 4790. https://www.mdpi.com/2072-6643/15/22/4790

  9. Hu, X., Chen, Y., Shen, Y., Tian, R., Sheng, Y., & Que, H. (2022). Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A systematic review and meta-analysis. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.1020709

  10. Jacobson, M. H., Howards, P. P., Darrow, L. A., Meadows, J. W., Kesner, J. S., Spencer, J. B., Terrell, M. L., & Marcus, M. (2018). Thyroid hormones and menstrual cycle function in a longitudinal cohort of premenopausal women. Paediatric and perinatal epidemiology, 32(3), 225–234. https://doi.org/10.1111/ppe.12462

  11. Krishnamurthy, H. K., Reddy, S., Jayaraman, V., Krishna, K., Song, Q., Rajasekaran, K. E., Wang, T., Bei, K., & Rajasekaran, J. J. (2021). Effect of Micronutrients on Thyroid Parameters. Journal of thyroid research, 2021, 1865483. https://doi.org/10.1155/2021/1865483

  12. Ling, C., Sun, Q., Khang, J., Felipa Lastarria, M., Strong, J., Stolze, B., Yu, X., Parikh, T. P., Waldman, M. A., Welsh, K., Jonklaas, J., Masika, L., & Soldin, S. J. (2018). Does TSH Reliably Detect Hypothyroid Patients?. Annals of thyroid research, 4(1), 122–125. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847294/

  13. Mikulska, A. A., Karaźniewicz-Łada, M., Filipowicz, D., Ruchała, M., & Główka, F. K. (2022). Metabolic Characteristics of Hashimoto’s Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management—An Overview. International Journal of Molecular Sciences, 23(12), 6580. https://doi.org/10.3390/ijms23126580

  14. NIDDK. (2022). Hypothyroidism (Underactive thyroid). National Institute of Diabetes and Digestive and Kidney Diseases.

  15. Pantalone, K. M., Hatipoglu, B., Gupta, M. K., Kennedy, L., & Hamrahian, A. H. (2015). Measurement of Serum Free Thyroxine Index May Provide Additional Case Detection Compared to Free Thyroxine in the Diagnosis of Central Hypothyroidism. Case reports in endocrinology, 2015, 965191. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686635/

  16. Patil, N., Rehman, A., Anastasopoulou, C., et al. (2024). Hypothyroidism. [Updated 2024 Feb 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519536/

  17. Rizzo, L. F. L., & Mana, D. L. (2020). Treatment of hypothyroidism in special situations. Medicina (B Aires), 80 Suppl 6:83-93. English. PMID: 33481737. https://pubmed.ncbi.nlm.nih.gov/33481737/

  18. Singh, S., & Sandhu, S. (2024). Thyroid Disease and Pregnancy. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538485/

  19. Soh, S. B., & Aw, T. C. (2019). Laboratory Testing in Thyroid Conditions - Pitfalls and Clinical Utility. Annals of laboratory medicine, 39(1), 3–14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143469/

  20. Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., & Köhrle, J. (2023). Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status. Thyroid: official journal of the American Thyroid Association, 33(9), 1013–1028. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517335/

  21. Vasileiou, M., Gilbert, J., Fishburn, S., & Boelaert, K. (2020). Thyroid disease assessment and management: Summary of nice guidance. BMJ, m41. https://doi.org/10.1136/bmj.m41

  22. Wilson, S. A., Stem, L. A., & Bruehlman, R. D. (2021, May 15). Hypothyroidism: diagnosis and treatment. AAFP. https://www.aafp.org/pubs/afp/issues/2021/0515/p605.html

  23. Wyne, K. L., Nair, L., Schneiderman, C. P., Pinsky, B., Antunez Flores, O., Guo, D., Barger, B., & Tessnow, A. H. (2022). Hypothyroidism Prevalence in the United States: A Retrospective Study Combining National Health and Nutrition Examination Survey and Claims Data, 2009-2019. Journal of the Endocrine Society, 7(1), bvac172. https://doi.org/10.1210/jendso/bvac172

  24. Xu, W., Huang, Y., Ma, L., Chen, P., Li, S., Chu, K., Lan, Y., Li, C., Song, Y., Ying, Q., & Zhou, J. (2023). Clinical observation of menopause hormone therapy in postmenopausal women with euthyroid and mild subclinical hypothyroidism. BMC endocrine disorders, 23(1), 21. https://doi.org/10.1186/s12902-023-01269-7

  25. Zhao, R., Zhang, W., Ma, C., Zhao, Y., Xiong, R., Wang, H., Chen, W., & Zheng, S. G. (2021). Immunomodulatory Function of Vitamin D and Its Role in Autoimmune Thyroid Disease. Frontiers in immunology, 12, 574967. https://doi.org/10.3389/fimmu.2021.574967